Elevance Health, Inc. last reported quarterly results on Oct 21, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $51.4 billion (+1.4% year over year) and diluted EPS of $6.27. It usually reports 15–28 days after a quarter ends. Based on that pattern, the next release is estimated for around Jan 27, 2027.
Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Wednesday. Based on last year's release for the same quarter on Jan 28, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 15–28 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Oct 21, 2026
21 days after quarter end
|
Q3 FY2026
ended Sep 30, 2026
|
51,429
+1.4%
|
1,365
+14.8%
|
6.27
+17.9%
|
|
Jul 15, 2026
15 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
50,474
+1.4%
|
1,463
-16.1%
|
6.71
-13.1%
|
|
Apr 22, 2026
22 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
50,181
+2.6%
|
1,764
-19.2%
|
8.00
-16.8%
|
|
Jan 28, 2026
28 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
49,747
+9.5%
|
547
+30.9%
|
2.47
+36.3%
|
|
Oct 21, 2025
21 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
50,711
+12.4%
|
1,189
+17.0%
|
5.32
+22.0%
|
|
Jul 17, 2025
17 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
49,776
+13.4%
|
1,743
-24.2%
|
7.72
-21.6%
|
|
Apr 17, 2025
17 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
48,891
+14.8%
|
2,183
-2.8%
|
9.61
+0.2%
|
|
Jan 23, 2025
23 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
45,442
+6.6%
|
418
-51.2%
|
1.81
-50.2%
|
Company profile
- Industry
- Hospital & Medical Service Plans (SIC 6324)
- Listed as
- ELV (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- IN
- Headquarters
- Indianapolis, IN
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1156039
- Former names
- Anthem, Inc. (until Jun 24, 2022); WELLPOINT, INC (until Nov 12, 2014); WELLPOINT INC (until Dec 21, 2009); ANTHEM INC (until Nov 30, 2004)
Other Hospital & Medical Service Plans companies
- Unitedhealth Group Inc UNH
- Cigna Group CI
- Humana Inc HUM
- Centene Corp CNC
- Molina Healthcare, Inc. MOH
- Oscar Health, Inc. OSCR
- Clover Health Investments, Corp. /DE CLOV
- Alignment Healthcare, Inc. ALHC
Source: SEC EDGAR filings. This is company-reported data, not investment advice.